Health Care REIT Inc said it would buy Canada's HealthLease Properties Real Estate Investment Trust in a deal valued at $950 million, including debt, to expand its presence in senior housing and post-acute care segments.
Medical device maker Hologic Inc is buying diagnostic test firm Gen-Probe Inc for $3.75 billion cash, gaining access to molecular diagnostics products used to screen for blood diseases and test transplant compatibility.
Spectrum Pharmaceuticals Inc said its experimental drug to treat a common form of bladder cancer failed to significantly reduce the recurrence of tumors in late-stage trials, sending its shares down 14 percent.
Discovery Laboratories Inc said U.S. health regulators have approved its drug to prevent a breathing disorder in premature infants, sending its shares up 35 percent in extended trade.
The U.S. patent office has rejected a patent application from Amarin Corp Plc for its key experimental heart drug.
Feb 29 The U.S. patent office has rejected
a patent application from Amarin Corp Plc for its key
experimental heart drug.
Infinity Pharmaceuticals pulled the plug on a mid-stage trial of its experimental pancreatic cancer drug as it failed to show benefit over a placebo, wiping off over 41 percent of its market value.